Toxic megacolon is a severe complication of Clostridium difficile infection (CDI) with a high percentage of mortality. The mainstay of treatment is currently represented by medical management, while surgical intervention is indicated in patients not improving after 2-3 days of antibiotic therapy. Generally metronidazole and vancomycin are administered as first-line treatment, but recently several cases of refractory C. difficile have made the treatment of this infection more difficult. Fidaxomicin is a narrow-spectrum oral macrocyclic antibiotic with excellent in vitro activity against C. difficile strains. We report the case of a woman admitted with a diagnosis of toxic megacolon complicating a C. difficile colitis not responding to standa...
The two drugs currently recommended for the treatment of Clostridium difficile infection (CDI), name...
Clostridium difficile infection (CDI) is a potential life-threatening consequence of antibiotic ther...
Fidaxomicin is a macrocyclic antibiotic licensed for treating Clostridium difficile infection (CDI)....
Clostridium difficile infection (CDI) is the main cause of hospital-acquired diarrhea. It can result...
© 2017, Serbian Medical Society. All rights reserved. Hyper virulent bacterial strain and irrational...
The incidence of Clostridium difficile infections (CDI) and Clostridium difficile-Associated Diarrhe...
Until recently, treatment of Clostridium difficile infection (CDI) was mainly limited to oral metron...
Introduction: Toxic megacolon is a life-threatening disease and is one of the most serious complicat...
AbstractUntil recently, treatment of Clostridium difficile infection (CDI) was mainly limited to ora...
Toxic megacolon is a fatal condition defined as a rare, life-threatening, acute colonic dilatation o...
Clostridium difficile has been historically viewed as a hospital acquired infection. However, the em...
The incidence and mortality rate of C. difficile infection (CDI) has increased remarkably over the l...
Clostridium difficile colitis is a substantial cause of in-hospital morbidity. Since the mortality a...
Recent outbreaks of Clostridium difficile infection (CDI) in North America have been due to a more v...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
The two drugs currently recommended for the treatment of Clostridium difficile infection (CDI), name...
Clostridium difficile infection (CDI) is a potential life-threatening consequence of antibiotic ther...
Fidaxomicin is a macrocyclic antibiotic licensed for treating Clostridium difficile infection (CDI)....
Clostridium difficile infection (CDI) is the main cause of hospital-acquired diarrhea. It can result...
© 2017, Serbian Medical Society. All rights reserved. Hyper virulent bacterial strain and irrational...
The incidence of Clostridium difficile infections (CDI) and Clostridium difficile-Associated Diarrhe...
Until recently, treatment of Clostridium difficile infection (CDI) was mainly limited to oral metron...
Introduction: Toxic megacolon is a life-threatening disease and is one of the most serious complicat...
AbstractUntil recently, treatment of Clostridium difficile infection (CDI) was mainly limited to ora...
Toxic megacolon is a fatal condition defined as a rare, life-threatening, acute colonic dilatation o...
Clostridium difficile has been historically viewed as a hospital acquired infection. However, the em...
The incidence and mortality rate of C. difficile infection (CDI) has increased remarkably over the l...
Clostridium difficile colitis is a substantial cause of in-hospital morbidity. Since the mortality a...
Recent outbreaks of Clostridium difficile infection (CDI) in North America have been due to a more v...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
The two drugs currently recommended for the treatment of Clostridium difficile infection (CDI), name...
Clostridium difficile infection (CDI) is a potential life-threatening consequence of antibiotic ther...
Fidaxomicin is a macrocyclic antibiotic licensed for treating Clostridium difficile infection (CDI)....